The Study Of CT Scans and Echo Parameters in Patients With PAH

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00625963
First received: February 20, 2008
Last updated: July 29, 2013
Last verified: July 2013
  Purpose

Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.


Condition
Pulmonary Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Study of CT Scan and Echocardiogram Parameters in Patients With Pulmonary Hypertension With Regards to Hemodynamics, Sleep Studies, and Various Laboratory Markers.

Resource links provided by NLM:


Further study details as provided by North Shore Long Island Jewish Health System:

Primary Outcome Measures:
  • The Study Of CT Scans and Echo Parameters in Patients With PAH [ Time Frame: All data has been previously collected. ] [ Designated as safety issue: No ]
    Correlation of Pulmonary artery diameter as measured by CT scan and Pulmonary artery systolic pressure as measured by Echocardiogram.


Enrollment: 71
Study Start Date: April 2007
Study Completion Date: July 2011
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
I,A
I=Pulmonary Hypertension Patients A=ILD patients with Pulmonary Hypertension Patients

Detailed Description:

The goal of our study is to correlate data from various non-invasive tests such as commuted tomography (CT) imaging, echocardiogram, Pulmonary Function Tests, and other laboratory tests along with hemodynamic measurements from Right Heart Catheterizations in these ILD patients with Pulmonary Hypertension, as well as all other pulmonary hypertension. The ultimate goal is to determine patterns of the PAH disease processes, as well as define optimal diagnostic modalities including in-hospital verses outpatient studies.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pulmonary Arterial Hypertension; Idiopathic Lung Disease

Criteria

Inclusion Criteria:

  • Pulmonary Hypertension;
  • ILD with Pulmonary Hypertension

Exclusion Criteria:

  • NON-PH
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00625963

Locations
United States, New York
North Shore-Long Island Jewish Health System
New Hyde Park, New York, United States, 11040
Sponsors and Collaborators
North Shore Long Island Jewish Health System
Investigators
Principal Investigator: Arunabh Talwar, MD North Shore-LIJ Health System
  More Information

No publications provided

Responsible Party: North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier: NCT00625963     History of Changes
Other Study ID Numbers: 07.060
Study First Received: February 20, 2008
Last Updated: July 29, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:
Pulmonary Hypertension;
ILD;
CT Imaging;
Echocardiogram;
Hemodynamic measurements of RHC.
Pulmonary Function Tests

Additional relevant MeSH terms:
Hypertension
Hypertension, Pulmonary
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 22, 2014